VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis - Wikidata - awgldk - TriplyDB

VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis

VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis

http://www.wikidata.org/entity/Q36403416

about

Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells Cluster analysis of networks generated through homology: automatic identification of important protein communities involved in cancer metastasis S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis Broad targeting of angiogenesis for cancer prevention and therapy Filarial excretory-secretory products induce human monocytes to produce lymphangiogenic mediators r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction Walking the Line: A Fibronectin Fiber-Guided Assay to Probe Early Steps of (Lymph)angiogenesis Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development Vascular endothelial growth factor C-induced lymphangiogenesis decreases tumor interstitial fluid pressure and tumor Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow.Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis.Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse.FcγRIIB and autoimmunity.NIR spectroscopic detection of breast cancer.Tumor cell plasticity and angiogenesis in human melanomas An in vivo chemical library screen in Xenopus tadpoles reveals novel pathways involved in angiogenesis and lymphangiogenesis Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer.Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.Cancer stem cells and tumor metastasis (Review).Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer.Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease.Lymphangiogenesis and its correlation with the VEGF expression and the sentinel lymph node in cutaneous melanomas.Slit-Robo signaling mediates lymphangiogenesis and promotes tumor lymphatic metastasis.Hepatocyte growth factor promotes lymphatic vessel formation and function.Lymphangiogenesis and lymphatic metastasis in breast cancer.The lymphatic system in health and disease.Lymphangiogenesis: a new player in cancer progression.Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.Current views on the function of the lymphatic vasculature in health and disease miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A.VP23R of infectious spleen and kidney necrosis virus mediates formation of virus-mock basement membrane to provide attaching sites for lymphatic endothelial cells.Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer.A role for all-trans-retinoic acid in the early steps of lymphatic vasculature development.

P2860

Q24298455-4BF1B1D9-8CF1-48B2-A082-A925C39A7D81 Q24318473-FF8F5930-E457-41CD-B870-4106C26EB048 Q24537769-68804A59-8AC3-43AA-84B5-5FC8443B6F43 Q24650866-E84DEBE4-4C3C-4AE7-BA3E-087720A029C4 Q26778332-FE1D05C6-A3CA-4387-A2FF-E4908F8B1D8C Q26865533-25C8FC4B-16EA-44BB-AA08-959348B42464 Q27002903-11B4553B-8065-4B05-A452-2B57FE4C5B77 Q27304880-438A3806-DD74-4719-A951-9E9555666B40 Q27321768-6C79B01A-63DB-455A-9584-7FCFCCF44CE7 Q27334494-9987D5E8-03ED-4AAE-812E-D06041D88FC6 Q28586394-A8D4A709-EEAE-41A4-AA70-4922502381D4 Q30451661-A9E529C4-FFA7-4CB9-8275-91C1CA904CEC Q30482388-B4CEE29F-73C8-4C4F-A49F-19B9F08202A1 Q30488797-21C8C24E-37BF-4785-9A5C-0B136CC559AA Q30498120-52573545-42E9-41E8-B0D2-DFACC9B23F01 Q30499924-9624BF69-2D58-4481-A8B9-791903F671AB Q30981881-626C5287-C679-4370-A5C8-E1B8CD1E66EF Q31005913-351F0E55-1E4D-44D2-AE2A-DDDA93CF6B9E Q31052984-14AC1210-9873-4B07-BCA3-773E2B340E5A Q33455334-FAA125A3-1ED5-4F4F-B396-477DDA6EA40C Q33565805-3982C356-0D9F-4AF6-AB0A-CEE2FBC8F5D4 Q33575116-CA7E8D34-DDC0-4841-ADD2-8EEFB2BFA61A Q33665758-80A372D0-82F4-4E36-B6C1-8BF8F8A5162D Q33778124-B4017E00-E0DD-42EA-B832-F092C3FA5F63 Q33778640-8C36C3E8-83D3-4094-BA84-03BE04FE808F Q33795240-DB3B569F-9704-4296-A4CA-EF7369195EEB Q33831778-88994ECC-C17D-4FC8-841A-42E3AE97EE6E Q33894060-2BC329DE-AF21-48AF-BDEC-FDB348CA1765 Q33918407-9805ADD7-D8DC-4EF9-BC65-2C596E494A79 Q33919993-74786CD1-84A8-4396-B2C2-520F250B2048 Q33940058-E4D10581-83A9-4816-B945-44AA34E227EC Q34015299-6945BD56-76EE-472A-A00C-659A3B967E4D Q34084937-21529787-3B53-4A7F-A5FE-F7FB8D1C5008 Q34098683-064B7F83-56BA-46A2-B7D3-88614C69D7EC Q34161479-FF5A1CA1-146B-4DC7-96EB-977F9EABF36F Q34164880-6EACF612-4FA7-43D0-8A15-FC5C33EDCA1C Q34179800-30292182-6E3F-4D50-9F8F-E55EBCFDD8E6 Q34296128-5AA94834-9A88-4FA7-ACB4-4F395D1E7E54 Q34343963-28E50E0A-4782-4587-8EAB-F5C9D8CD3F9B Q34382211-2ACBA74F-EB3E-4CC5-898D-864B0DF8A136

P2860

VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis

http://www.wikidata.org/entity/Q36403416

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

VEGF-A induces tumor and senti ...... promotes lymphatic metastasis

@ast

VEGF-A induces tumor and senti ...... promotes lymphatic metastasis

@en

type

label

VEGF-A induces tumor and senti ...... promotes lymphatic metastasis

@ast

VEGF-A induces tumor and senti ...... promotes lymphatic metastasis

@en

prefLabel

VEGF-A induces tumor and senti ...... promotes lymphatic metastasis

@ast

VEGF-A induces tumor and senti ...... promotes lymphatic metastasis

@en

P1433

Q36403416-C82EB09E-4F25-4B67-AE75-277720424CE0

P1476

Q36403416-FFDA0624-F9C9-4F26-9B8F-F30218E6163C

P2093

Q36403416-3595807E-BD26-4220-9418-69652A99B9F3

Q36403416-9361ED9D-5EF1-479D-801B-D216A3A9242C

Q36403416-AA2CFB76-6B55-4443-A6BF-87CC3A5C5418

Q36403416-B8166824-10A7-405F-9300-33C07F2300A2

Q36403416-D777EBCD-84EA-49DA-BD0A-BD73954FCDD8

P2860

Q36403416-07BF9AE4-13E5-4843-AAEE-AE0D5E48512F

Q36403416-0FF00CA2-C43B-4A45-8A08-8F255876E4A2

Q36403416-10CE8954-D830-4B1A-B6BA-FB99F327AA7B

Q36403416-12DC4EB7-04DC-4C60-86CC-F05DF507EDD0

Q36403416-2168D9E3-7DDC-4314-92B7-DF08C3ED8241

Q36403416-2FE2649C-29AB-4623-A7FE-33B64A604938

Q36403416-38F8EA2F-387A-46AD-8679-D8F39014547B

Q36403416-3DF8BE5B-B28D-4B8C-B21B-936B99297693

Q36403416-4DADF109-3275-44BF-A39C-DA175D9AD92C

Q36403416-4F465DC5-D2CC-45C1-BB8E-EE25D11C8E9E

P304

Q36403416-7F613C9D-8BBA-45B5-A735-CF5B8504227E

P31

Q36403416-B1D421EA-23F3-4980-889C-4306D0565EC9

P356

Q36403416-94E2D018-0F5B-41B5-8933-9F0ABC205EEF

P407

Q36403416-34CCD009-E8E8-4A88-9FA5-619B3697E5E7

P433

Q36403416-C4BFC656-8BF8-4599-BC77-42E79775E735

P478

Q36403416-50DE1C65-ABB9-48E9-83F8-CF5F0A703C8C

P50

Q36403416-F21B14BC-B63F-4CD5-9769-2FCF4BF4C6EC

P577

Q36403416-C73C4B13-F386-49EB-8019-837C863395E8

P5875

Q36403416-5E514B14-0360-48B1-93AC-6B8AE399DB85

P698

Q36403416-8DD327CE-C9F2-49B7-AFBC-9E2737DC62A9

P921

Q36403416-6A60275A-D10B-4BE1-985C-B364637356DE

Q36403416-8E4B0394-B366-466C-AA98-C16200FEC187

P932

Q36403416-C57AC5F5-DAEC-48F7-B7D7-8AF5BFD604D3

P356

P1433

Journal of Experimental Medicine

P1476

VEGF-A induces tumor and senti ...... promotes lymphatic metastasis

@en

P2093

Kentaro Kajiya

http://www.w3.org/2001/XMLSchema#string

Lawrence F Brown

http://www.w3.org/2001/XMLSchema#string

Rainer Kunstfeld

http://www.w3.org/2001/XMLSchema#string

Satoshi Hirakawa

http://www.w3.org/2001/XMLSchema#string

Shohta Kodama

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism.

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis

The biology of VEGF and its receptors

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.

LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis

Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium

Angiogenesis in health and disease

P304

1089-1099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20041896

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

201

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7927633

http://www.w3.org/2001/XMLSchema#string

P698

15809353

http://www.w3.org/2001/XMLSchema#string

P921

lymphangiogenesis

P932

2213132

http://www.w3.org/2001/XMLSchema#string